Parallax Volatility Advisers
AXDX

Parallax Volatility Advisers’s Accelerate Diagnostics AXDX Stock Holding History

Parallax Volatility Advisers’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,540
Closed -$1.47M – 3946
2017
Q3 		$1.47M Buy
6,540
+160
+3% +$39.3K ﹤0.01% 941
2017
Q2 		$1.75M Buy
+6,380
New +$1.73M ﹤0.01% 879

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Parallax Volatility Advisers's AXDX Position: Q4 2018 in Review

Parallax Volatility Advisers sold out of Accelerate Diagnostics (AXDX) in Q4 2018, closing a stake of 1,084 shares — an estimated $161K sold.

Parallax Volatility Advisers first reported a position in AXDX in Q2 2017 and held it in 5 quarters. The position peaked at $710K in Q2 2017. 107 funds tracked by Wall St. Rank hold AXDX as of Q4 2018.

  • Parallax Volatility Advisers reported no remaining Accelerate Diagnostics position as of Q4 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 1,084 Accelerate Diagnostics shares in Q4 2018, an estimated $161K.
  • Parallax Volatility Advisers first reported a position in Accelerate Diagnostics in Q2 2017 and held it in 5 quarters.
  • Parallax Volatility Advisers's Accelerate Diagnostics position peaked at $710K in Q2 2017.
  • 107 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2018.

Based on Parallax Volatility Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.